Hirokazu Nagai
-
- Lymphoma Diagnosis and Treatment 73
- Hematology top 2%
- Multiple Myeloma Research and Treatments 10
- Oncology top 5%
- Viral-associated cancers and disorders 38
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 27
-
- CNS Lymphoma Diagnosis and Treatment 15
-
- T-cell and Retrovirus Studies 13
-
- Cancer-related gene regulation 9
- Epigenetics and DNA Methylation 9
- Co-authors
- Tomohiro KinoshitaTomomitsu HottaHidehiko SaitoTakashi MurateMasayuki FukudaToshiki UchidaYouji MiyamotoTetsuya Tamatani
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Hirokazu Nagai
155 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 114
- Complementary and Manual Therapy 108
- Pathology and Forensic Medicine 761
- Hematology 390
- Oncology 949
- Genetics 332
Countries citing papers authored by Hirokazu Nagai
This map shows the geographic impact of Hirokazu Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Nagai more than expected).
Fields of papers citing papers by Hirokazu Nagai
This network shows the impact of papers produced by Hirokazu Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Nagai. The network helps show where Hirokazu Nagai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirokazu Nagai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2019 | 6 | |
| 12 | 2019 | 7 | |
| 13 | 2018 | 5 | |
| 14 | 2017 | 24 | |
| 15 | 2016 | 0 | |
| 16 | 2009 | 16 | |
| 17 | 2003 | 55 | |
| 18 | 2000 | 4 | |
| 19 | 1996 | 8 | |
| 20 | [A case control study of breast cancer, mammary cyst and dietary, drinking or smoking habit in Japan]. | 1990 | 2 |
About Hirokazu Nagai
Hirokazu Nagai is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 164 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (73 papers), Viral-associated cancers and disorders (38 papers), Chronic Lymphocytic Leukemia Research (27 papers), CNS Lymphoma Diagnosis and Treatment (15 papers), T-cell and Retrovirus Studies (13 papers), Multiple Myeloma Research and Treatments (10 papers), Cancer-related gene regulation (9 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Complementary and Manual Therapy (108 citations), Pathology and Forensic Medicine (761 citations) and Hematology (390 citations). Hirokazu Nagai has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Tomohiro Kinoshita, Tomomitsu Hotta, Hidehiko Saito, Takashi Murate, Masayuki Fukuda, Toshiki Uchida, Youji Miyamoto, Tetsuya Tamatani, Daisuke Uchida and Takashi Watanabe. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.